Patients with cancer, who’ve had at least one previous treatment and whose tumor tissue shows a specific genetic mutation, could be eligible for one of many clinical trials each testing a novel oral agent.
Investigator: Bill G Schmidt, MD
Sponsor: Novartis Pharmaceuticals
Contact: Christine Reed, 541-706-6592 or firstname.lastname@example.org
Location: Bend, Oregon (Central Oregon)
Click on the links below to see details of the included individual trials at ClinicalTrials.gov:
For general inquiries, please contact the BMC Research Department at email@example.com or 877-692-8338.